ALIVUS LIFE SCIENCES
Back to Balance Sheet
|
ALIVUS LIFE SCIENCES Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹682 Cr | ₹470 Cr | ₹439 Cr | ₹1,015 Cr | ₹747 Cr |
What is the latest Total Current Liabilities ratio of ALIVUS LIFE SCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹682 Cr |
| Mar2025 | ₹470 Cr |
| Mar2024 | ₹439 Cr |
| Mar2023 | ₹1,015 Cr |
| Mar2022 | ₹747 Cr |
How is Total Current Liabilities of ALIVUS LIFE SCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹682 Cr | 45.11 | |
| Mar2025 | ₹470 Cr | 7.15 | |
| Mar2024 | ₹439 Cr | -56.77 | |
| Mar2023 | ₹1,015 Cr | 35.90 | |
| Mar2022 | ₹747 Cr | - | |
Compare Total Current Liabilities of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹16,785.5 Cr | -2.7% | 3.4% | 51.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | -2.7% |
3.4% |
51.4% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses